Zobrazeno 1 - 10
of 41
pro vyhledávání: '"S E, Krown"'
Autor:
Margaret Borok, Paul G. Rubinstein, Thomas B. Campbell, Ethel Cesarman, A. Semeere, D. Wirth, S. E. Krown, Stanley Chang, Jeffrey N. Martin, C. M. Genovese, S. Soo Mun, J. Alvarez, Jennifer Totonchy, D. A. Scheinberg, M. Bott, Tao Dao, M. Ibanez de Garayo, A. Gautam, M. Horenstein, J. Delgado de la Mora, Ayana Morales
PurposeWilms’ tumor 1 (WT1) is overexpressed in several cancers, and WT1 expression levels are associated with poor prognosis. As a host protein that functions as an oncogene, it represents an important immunotherapeutic target. This study evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5868126fde606915ae3fd498cda8f38c
https://doi.org/10.1101/2021.02.20.21251636
https://doi.org/10.1101/2021.02.20.21251636
Autor:
S E Krown, R Levine, B J Dezube, G M Dosik, J H Von Roenn, J A Thommes, C. E. Dumond, R D Mamelok, A Rios, Donald W. Northfelt
Publikováno v:
Journal of Clinical Oncology. 15:653-659
PURPOSE To determine the efficacy and safety of pegylated-liposomal doxorubicin in patients with AIDS and Kaposi's sarcoma (AIDS-KS) who experienced failure of standard chemotherapy. METHODS Fifty-three patients with advanced AIDS-KS who experienced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77ba42fc7a1716b51394845faefd294b
https://doi.org/10.1200/jco.1997.15.2.653
https://doi.org/10.1200/jco.1997.15.2.653
Autor:
S E Krown
Publikováno v:
Journal of Clinical Oncology. 9:2235-2237
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e056a8446e2ca939831ccf2c99f8d332
https://doi.org/10.1200/jco.1991.9.12.2235
https://doi.org/10.1200/jco.1991.9.12.2235
Autor:
S E, Krown
Publikováno v:
The Medical clinics of North America. 81(2)
Kaposi's Sarcoma (KS), the most common AIDS-associated malignancy, occurs with increased frequency in all HIV transmission groups, but at a particularly high rate in homosexual men. Recent studies suggest that KS pathogenesis involves exposure to an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ee6c4c464d601a31885fe728ae97fa1
https://pubmed.ncbi.nlm.nih.gov/9093238
https://pubmed.ncbi.nlm.nih.gov/9093238
Autor:
D, Mildvan, Y, Bassiakos, M L, Zucker, N, Hyslop, S E, Krown, H S, Sacks, J, Zachary, J, Paredes, W J, Fessel, F, Rhame, F, Kramer, M A, Fischl, B, Poiesz, K, Wood, R M, Ruprecht, J, Kim, S E, Grossberg, P, Kasdan, P, Bergé, A, Marshak, C, Pettinelli
Publikováno v:
Antiviral therapy. 1(2)
Thirty-four subjects with symptomatic HIV-1 infection, p24 antigenaemia, and CD4 cell counts200/mm3 were randomly assigned to receive treatment with either zidovudine (ZDV) orally, interferon-alpha (IFN-alpha) subcutaneously, or both at respective lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30a3a46aeb89a00178f58c5bdce24264
https://pubmed.ncbi.nlm.nih.gov/11321183
https://pubmed.ncbi.nlm.nih.gov/11321183
Autor:
S E, Krown
Publikováno v:
Cancer chemotherapy and biological response modifiers. 16
Although currently diagnosed in about 40% of HIV-infected individuals at some point in their clinical course, AIDS-associated malignancies may increase in frequency as survival is prolonged and, particularly, as greater numbers of HIV infections occu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1f157050031fb7b2e0599a15d171f495
https://pubmed.ncbi.nlm.nih.gov/8639393
https://pubmed.ncbi.nlm.nih.gov/8639393
Autor:
J, Paredes, J O, Kahn, W P, Tong, M L, Feldstein, S, Lin, J M, Bennett, C E, Metroka, L, Ratner, S E, Krown
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 9(2)
We conducted a Phase I trial to evaluate the safety, maximally tolerated dose (MTD), antitumor activity, and pharmacology of once-weekly oral etoposide in patients with Kaposi's sarcoma (KS) and AIDS. From September 1990 to October 1991, 27 eligible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62526966ef80f9c1ba1b5d7c401cd928
https://pubmed.ncbi.nlm.nih.gov/7749790
https://pubmed.ncbi.nlm.nih.gov/7749790
Publikováno v:
Cancer. 71(7)
Zidovudine is a thymidine analogue that has been reported to have antiviral and antineoplastic activity in vitro.The case of a patient with acquired immune deficiency syndrome (AIDS) and a pulmonary non-Hodgkin lymphoma treated with zidovudine and no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20e43c2e58433f60d7dc10c0999a8890
https://pubmed.ncbi.nlm.nih.gov/8453555
https://pubmed.ncbi.nlm.nih.gov/8453555
Autor:
M A, Fischl, S E, Krown, K P, O'Boyle, R, Mitsuyasu, S, Miles, J C, Wernz, P A, Volberding, J, Kahn, J E, Groopman, J, Feinberg
Publikováno v:
Journal of acquired immune deficiency syndromes. 6(3)
Fifty-three patients with AIDS-related Kaposi's sarcoma and no previous treatment with cytotoxic chemotherapy enrolled in a phase II multicenter study to evaluate the safety and efficacy of weekly doxorubicin treatment. Doxorubicin was given intraven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67f6e64c9b5765e0cc2be03fef731153
https://pubmed.ncbi.nlm.nih.gov/8450401
https://pubmed.ncbi.nlm.nih.gov/8450401
Publikováno v:
Pathologie-biologie. 39(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4e914ea86459b62f5837526b9cfe02af
https://pubmed.ncbi.nlm.nih.gov/1538955
https://pubmed.ncbi.nlm.nih.gov/1538955